Reduced dopamine transporter availability in drug‐naive adult attention‐deficit/hyperactivity disorder
Psychiatry and Clinical Neurosciences Reports · 2024-03 · 3 (1)
DOI: 10.1002/pcn5.177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 18.02.2024. Verfasst von Shuntaro Itagaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry Fukushima Medical University Fukushima Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
This study aimed to clarify the abnormalities in dopamine transporter (DAT) availability in drug‐naive adult patients with attention‐deficit/hyperactivity disorder (ADHD) and the relationship between ADHD symptoms and abnormalities in DAT availability.
Methods
Single‐photon emission tomography (SPECT) was performed using iodine‐123‐β‐carbomethoxy‐3β‐(4‐iodophenyltropane) (I‐123 β CIT) as a tracer to measure in vivo DAT availability in 20 drug‐naive patients with ADHD [mean age ± standard deviation (SD)]: 25 ± 3.44 years; male:female = 11:9] and 20 age‐ and sex‐matched healthy controls (HCs) (mean age ± SD: 23.9 ± 2.27 years). Comparisons of DAT availability between HCs and adult patients with ADHD and the association between symptom severity and DAT availability within the ADHD group were analyzed using Statistical Parametric Mapping 12.
Results
Drug‐naive adults with ADHD showed significantly reduced DAT availability in the bilateral nucleus accumbens compared with HCs. Correlation analyses revealed a negative correlation between the severity of inattentive symptoms in adult patients with ADHD and DAT availability in the bilateral heads of the caudate nucleus, indicating the association between severe inattentive symptoms and lower DAT availability in the caudate nucleus.
Conclusion
In drug‐naive adult patients with ADHD, DAT availability was reduced in the nucleus accumbens, an important part of the reward system. This finding indicates the importance of the DAT in the reward system in the pathogenesis of ADHD. Inattentiveness was associated with DAT availability in the caudate nucleus, suggesting involvement of the cortico‐striato‐thalamo‐cortical circuit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuropsychiatry Fukushima Medical University Fukushima Japan.
- Medical Affairs Division Janssen Pharmaceutical K.K Tokyo Japan.
- Department of Pathology of Mental Diseases, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo Japan.
- Department of Radiology and Nuclear Medicine Fukushima Medical University Fukushima Japan.
- Department of Mind & Brain Medicine Fukushima Medical University Fukushima Japan.
ORCID-Profile: Shuntaro Itagaki, Junya Matsumoto, Hirooki Yabe
Zitieren
APA
Itagaki, S., Ohnishi, T., Toda, W., Sato, A., Matsumoto, J., Ito, H., Ishii, S., Yamakuni, R., Miura, I., & Yabe, H. (2024). Reduced dopamine transporter availability in drug‐naive adult attention‐deficit/hyperactivity disorder. Psychiatry and Clinical Neurosciences Reports, 3(1). https://doi.org/10.1002/pcn5.177
Vancouver
Itagaki S, Ohnishi T, Toda W, Sato A, Matsumoto J, Ito H, et al. Reduced dopamine transporter availability in drug‐naive adult attention‐deficit/hyperactivity disorder. Psychiatry and Clinical Neurosciences Reports. 2024;3(1). doi:10.1002/pcn5.177
BibTeX
@article{Itagaki2024,
author = {Itagaki, Shuntaro and Ohnishi, Takashi and Toda, Wataru and Sato, Aya and Matsumoto, Junya and Ito, Hiroshi and Ishii, Shiro and Yamakuni, Ryo and Miura, Itaru and Yabe, Hirooki},
title = {Reduced dopamine transporter availability in drug‐naive adult attention‐deficit/hyperactivity disorder},
journal = {Psychiatry and Clinical Neurosciences Reports},
year = {2024},
volume = {3},
number = {1},
doi = {10.1002/pcn5.177}
}
EUVIMED